Silicone oil tamponade to seal macular holes without position restrictions

Ophthalmology

Volumn 105, Issue 11, 1998, Pages 2140-2148

  Goldbaum, Michael H ^a,b   McCuen II, Brooks W ^c   Hanneken, Anne M ^d   Burgess, Stuart K ^a   Chen, Howard H ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c DUKE UNIVERSITY   (United States)

^d San Diego Orthopaedic Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SILICONE OIL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; HUMAN; PATIENT POSITIONING; PRIORITY JOURNAL; RETINA MACULA HOLE; RETINA MACULOPATHY; TREATMENT OUTCOME; VISUAL ACUITY; VITRECTOMY;

EID: 0032471243     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(98)91140-X     Document Type: Article

References (19)

1. Kelly NE, Wendel RT. Vitreous surgery for idiopathic macular holes. Results of a pilot study. Arch Ophthalmol 1991; 109:654-9.
2. Wendel RT, Patel AC, Kelly NE, et al. Vitreous surgery for macular holes. Ophthalmology 1993;100:1671-6.
3. Freeman WR, Azen SP, Kim JW, et al. Vitrectomy for the treatment of full-thickness stage 3 or 4 macular holes. Results of a multicentered randomized clinical trial. The Vitrectomy for Treatment of Macular Hole Study Group. Arch Ophthalmol 1997;115:11-21.
4. Glaser BM, Michels RG, Kuppermann BD, et al. Transforming growth factor-beta 2 for the treatment of full-thickness macular holes. A prospective randomized study. Ophthalmology 1992;99:1162-72.
5. Liggett PE, Skolik SDS, Horio B, et al. Human autologous serum for the treatment of full-thickness macular holes. A preliminary study. Ophthalmology 1995;102:1071-6.
6. Gaudric A, Massin P, Paques M, et al. Autologous platelet concentrate for the treatment of full-thickness macular holes. Graefes Arch Clin Exp Ophthalmol 1995;233:549-54.
7. Del Priore LV, Kaplan HJ, Bonham RD. Laser photocoagulation and fluid-gas exchange for recurrent macular hole. Retina 1994;14:381-2.
8. Thompson JT, Smiddy WE, Glaser BM, et al. Intraocular tamponade duration and success of macular hole surgery. Retina 1996;16:373-82.
9. Gass JDM. Reappraisal of biomicroscopic classification of stages of development of a macular hole. Am J Ophthalmol 1995;119:752-9.
10. Ruby AJ, Williams DF, Grand MG, et al. Pars plana vitrectomy for treatment of stage 2 macular holes. Arch Ophthalmol 1994;112:359-64.
11. Federman JL, Schubert HD. Complications associated with the use of silicone oil in 150 eyes after retina-vitreous surgery. Ophthalmology 1988;95:870-6.
12. Marmor MF. Mechanisms of normal retinal adhesion. In: Ryan SJ, ed. Retina, 2nd ed. St. Louis: Mosby, 1994; v. 3, chap. 123.
13. Yoon YH, Marmor MF. Rapid enhancement of retinal adhesion by laser photocoagulation. Ophthalmology 1988; 95:1385-8.
14. Madreperla SA, Geiger GL, Funata M, et al. Clinicopathologic correlation of a macular hole treated by cortical vitreous peeling and tamponade. Ophthalmology 1994;101: 682-6.
15. Funata M, Wendel RT, de la Cruz Z, Green WR. Clinicopathologic study of bilateral macular holes treated with pars plana vitrectomy and gas tamponade. Retina 1992;12:289-98.
16. Gordon LW, Glaser BM, Ie D, et al. Full-thickness macular hole formation in eyes with a pre-existing complete posterior vitreous detachment. Ophthalmology 1995;102:1702-5.
17. Nagineni CN, Kutty RK, Detrick B, Hooks JJ. Inflammatory cytokines induce intercellular adhesion molecule-1 (ICAM-1) mRNA synthesis and protein secretion by human retinal pigment epithelial cell cultures. Cytokine 1996;8: 622-30.
18. Tornambe PE, Poliner LS, Grote K. Macular hole surgery without face-down positioning. A pilot study. Retina 1997;17: 179-85.
19. Casswell AG, Gregor ZJ. Silicone oil removal. II. Operative and postoperative complications. Br J Ophthalmol 1987;71: 898-902.